These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 15694263

  • 1. Response to chlorpromazine treatment may be associated with polymorphisms of the DRD2 gene in Chinese schizophrenic patients.
    Wu S, Xing Q, Gao R, Li X, Gu N, Feng G, He L.
    Neurosci Lett; 2005 Mar 07; 376(1):1-4. PubMed ID: 15694263
    [Abstract] [Full Text] [Related]

  • 2. Dopamine D2 receptor gene polymorphisms predict well the response to dopamine antagonists at therapeutic dosages in patients with schizophrenia.
    Sakumoto N, Kondo T, Mihara K, Suzuki A, Yasui-Furukori N.
    Psychiatry Clin Neurosci; 2007 Apr 07; 61(2):174-80. PubMed ID: 17362435
    [Abstract] [Full Text] [Related]

  • 3. Combination of dopamine D2 receptor gene polymorphisms as a possible predictor of treatment-resistance to dopamine antagonists in schizophrenic patients.
    Kondo T, Mihara K, Suzuki A, Yasui-Furukori N, Kaneko S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep 07; 27(6):921-6. PubMed ID: 14499308
    [Abstract] [Full Text] [Related]

  • 4. The influence on the schizophrenic symptoms by the DRD2Ser/Cys311 and -141C Ins/Del polymorphisms.
    Himei A, Koh J, Sakai J, Inada Y, Akabame K, Yoneda H.
    Psychiatry Clin Neurosci; 2002 Feb 07; 56(1):97-102. PubMed ID: 11929577
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Association study between antipsychotics- induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia.
    Kang SG, Lee HJ, Choi JE, Park YM, Park JH, Han C, Kim YK, Kim SH, Lee MS, Joe SH, Jung IK, Kim L.
    Neuropsychobiology; 2008 Feb 07; 57(1-2):49-54. PubMed ID: 18451638
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Association study between the -141C Ins/Del and TaqI A polymorphisms of the dopamine D2 receptor gene and alcoholism.
    Ishiguro H, Arinami T, Saito T, Akazawa S, Enomoto M, Mitushio H, Fujishiro H, Tada K, Akimoto Y, Mifune H, Shioduka S, Hamaguchi H, Toru M, Shibuya H.
    Alcohol Clin Exp Res; 1998 Jun 07; 22(4):845-8. PubMed ID: 9660310
    [Abstract] [Full Text] [Related]

  • 11. Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study.
    Sáiz PA, García-Portilla MP, Arango C, Morales B, Arias B, Corcoran P, Fernández JM, Alvarez V, Coto E, Bascarán MT, Bousoño M, Fañanas L, Bobes J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb 01; 34(1):26-31. PubMed ID: 19766158
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dopamine D4 receptor gene exon III polymorphism and interindividual variation in response to clozapine.
    Zhao AL, Zhao JP, Zhang YH, Xue ZM, Chen JD, Chen XG.
    Int J Neurosci; 2005 Nov 01; 115(11):1539-47. PubMed ID: 16223700
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Family based association study of DRD1, DRD2, DRD3, DRD4, DAT, COMT gene polymorphism in schizophrenia].
    Paweł K, Hauser J, Skibińska M, Szczepankiewicz A, Dmitrzak-Weglarz M, Gorzkowska K, Pawlak J, Czerski PM.
    Psychiatr Pol; 2010 Nov 01; 44(3):405-13. PubMed ID: 20672519
    [Abstract] [Full Text] [Related]

  • 19. Effect of DRD2, 5-HT2A, and COMT genes on antipsychotic response to risperidone.
    Yamanouchi Y, Iwata N, Suzuki T, Kitajima T, Ikeda M, Ozaki N.
    Pharmacogenomics J; 2003 Nov 01; 3(6):356-61. PubMed ID: 14610521
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.